$15.83
+0.13 (+0.83%)
As of Nov 5, 1:15 PM ET ·
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 6 60%
Hold 4 40%
Sell 0 0%
Price Target
Analyst Price Target +403.2% upside
Low Target $56.38
Average Target $79.65
High Target $102.54
Current Price $15.83
Current
$15.83
Target
$79.65
$56.38 $79.65 avg $102.54
Scenario Analysis
Bear Case
$56.38
256.2%
Low target
Base Case
$79.65
+403.2%
Avg target
Bull Case
$102.54
+547.8%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$21.74
-27.2% from high
52-Week Low
$9.23
+71.6% from low
50-Day SMA
$14.91
+6.2% vs SMA
200-Day SMA
$12.45
+27.1% vs SMA
RSI (14)
37.9
Neutral
Target vs 52W High
$79.65
+266.4% vs high
Next Earnings Report
Nov 11, 2026
4d
until earnings
EPS Est: $0.53
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -2.5%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +10.0%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.4%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +13.5%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +176.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.3%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +155.6%